Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 134-141

  Zhu, Meng Yang ^a   Ordway, Gregory A ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Desipramine; Down regulation; Norepinephrine transporter; PC12 cells; Tricyclic antidepressant

Indexed keywords

CITALOPRAM; DESIPRAMINE; NISOXETINE; NORADRENALIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE TRANSPORT; CELL STRAIN; CONCENTRATION RESPONSE; DOWN REGULATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0031019118     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010134.x     Document Type: Article

References (32)

1. 3H]-Desipramine binding to rat brain tissue: binding to both noradrenergic uptake sites and sites not related to noradrenaline neurons. J. Neurochem. 52, 1099-1106.
2. Barker E. L. and Blakely R. D. (1995) Norepinephrine and serotonin transporters. Molecular targets of antidepressant drugs, in Psychopharmacology. A Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 321-333. Raven Press, New York.
3. 3H]nisoxetine autoradiography. Brain Res. 582, 208-214.
4. Biegon A. (1986) Effect of chronic desipramine treatment on dihydroalprenolol, imipramine, and desipramine binding sites: a quantitative autoradiographic study in the rat brain. J. Neurochem. 47, 77-80.
5. Bönisch H. (1984) The transport of (+) amphetamine by the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch. Pharmacol. 327, 267-272.
6. s) and adenylyl cyclase. J. Neurochem. 64, 724-732.
7. Coppen A. (1967) The biochemistry of affective disorders. Br. J. Psychiatry 113, 1237-1264.
8. Fishman P. H. and Finberg J. P. M. (1987) Effects of the tricyclic antidepressant desipramine on β-adrenergic receptors in cultured rat glioma C6 cells. J. Neurochem. 49, 282-289.
9. 3H]nisoxetine binding in rat brain. J. Neurochem. 64, 2792-2800.
10. Glowinski J. and Axelrod J. (1964) Inhibition of uptake of tritiated norepinephrine in the intact rat brain by imipramine and structurally related compounds. Nature 204, 1318-1319.
11. Green L. A. and Rein G. (1977) Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells. Brain Res. 129, 247-263.
12. Harder R. and Bönisch H. (1985) Effects of monovalent ions on the transport of norepinephrine across the plasma membrane of neuronal cells (PC-12 cells). J. Neurochem. 45, 1154-1162.
13. Iversen L. L. and Kravitz E. A. (1966) Na dependence of transmitter uptake at adrenergic nerve terminals. Mol. Pharmacol. 2, 360-362.
14. Jayanthi L. D., Prasad P. D., Ramamoorthy S., Mahesh V. B., Leibach F. H., and Ganapathy V. (1993) Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. Biochemistry 32, 12178-12185.
15. 3H] imipramine binding are not associated with noradrenaline and serotonin uptake in the brain. Eur. J. Pharmacol. 78, 491-493.
16. Lee C.-M., Javitch J. A., and Snyder S. H. (1983) Recognition sites for norepinephrine uptake: regulation by neurotransmitter. Science 220, 626-629.
17. Lew R., Vaughan R., Simantov R., Wilson A., and Kuhar M. J. (1991) Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights. Synapse 8, 152-153.
18. Lorang D., Amara S. G., and Simerly R. B. (1994) Cell-type-specific expression of catecholamine transporters in the rat brain. J. Neurosci. 14, 4903-4914.
19. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
20. Pacholczyk T., Blakely R. D., and Amara S. G. (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354.
21. Patel A., Uhl G., and Kuhar M. J. (1993) Species differences in dopamine transporters: postmorterm changes and glycosylation differences. J. Neurochem. 61, 496-500.
22. Pepin M.-C., Govindan M. V., and Barden N. (1992) Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol. 41, 1016-1022.
23. Peterson G. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356.
24. Prien R. F. and Kocsis J. H. (1995) Long-term treatment of mood, in Psychopharmacology. A Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 1067-1079. Raven Press, New York.
25. Racagni G., Mocchetti I., Calderini G., Battistella A., and Brunello N. (1983) Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions. Neuropharmacology 22, 415-424.
26. Schildkraut J. J. (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122, 509-522.
27. Schubert D. and Klier F. G. (1977) Storage and release of acetylcholine by a clonal cell line. Proc. Natl. Acad. Sci. USA 74, 5184-5188.
28. Schwaninger M., Schöfl C., Blume R., Rössig L., and Knepel W. (1995) Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 47, 1112-1118.
29. 2 receptors. Mol. Brain Res. 27, 337-341.
30. Szot P., Ashliegh E. A., Kohen R., Petrie E., Dorsa D. M., and Veith R. (1993) Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment. Brain Res. 618, 308-312.
31. 3H] Nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharmacol. Exp. Ther. 260, 427-436.
32. Wong D. T., Threlkeld P. G., Best K. L., and Bymaster F. P. (1982) A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J. Pharmacol. Exp. Ther. 222, 61-65.